Tag archief: English Only

Egle Therapeutics Appoints Pierre Legault as Chairman and Board Member

PARIS–(BUSINESS WIRE)– Egle Therapeutics SAS (Egle), an emerging biotechnology company dedicated to developing novel immunotherapies for oncology and autoimmune diseases, is pleased to announce Pierre...

Allspring Global Investments Expands Presence in Italy With New Office Opening and Hire

LONDON–(BUSINESS WIRE)– Allspring Global Investments (Allspring), a leading independent asset manager with more than US$541 billion in assets under management*, today announced the appointment of...

Global Processing Services names Simon Stanford as Chief Revenue Officer

LONDON–(BUSINESS WIRE)– Global Processing Services (GPS), a leading global payment technology platform, has today announced the appointment of Simon Stanford as Chief Revenue Officer. Based...

ADVA plays key role in new QKD projects to accelerate commercial rollout

News summary: The emergence of quantum computers poses a major risk to public key cryptography Industry-led projects are laying the foundation for robust, cost-effective and...

SES Q1 2022 Results

“Solid start to 2022 with financial outlook and growth investments on track” SES S.A. announces financial results for the three months ended 31 March 2022....

Rimini Street Announces Fiscal First Quarter 2022 Financial Results

Quarterly revenue of $97.9 million, up 11.4% year over year Gross margin of 62.0%, up from 61.5% year over year Quarterly Billings of $97.7 million,...

Lunaphore and Visiopharm Announce New Partnership to Offer Spatial Biology Research Solution With Deep Learning Technology

Partnership to unify spatial staining and imaging with A.I. analysis technologies in end-to-end solution for researchers studying cancer and other diseases. LAUSANNE, Switzerland & HØRSHOLM,...

Phenom Recognized as a Strategic Leader in Fosway’s 2022 9-Grid™ for Talent Acquisition for Second Consecutive Year

Position solidifies Phenom’s continued adoption and proven ability to meet increasing talent demands across EMEA LONDON–(BUSINESS WIRE)– Phenom, the leading AI-powered talent experience platform, has...

Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus® Auto-Injector

The Aidaptus® disposable auto-injector platform, designed by Owen Mumford, will be jointly offered to global biopharma companies to support their drug development programs with engineering...

PayRetailers Strengthens Its Operations in Latin America

Spanish company PayRetailers continues to strengthen its local operations in Latin America and announces the opening of its new offices in Peru, while continuing to...

Aquanima Grupo Santander Wins Prestigious El Diamante de la Compra 2022 Award for Procurement Innovation Through its Partnership with Globality

Recognised by Spanish procurement industry body AERCE (Association of Purchasing, Contracting and Procurement Professionals) for utilizing AI-powered technology to transform the way it buys B2B...

BlueConic Named a Leader in IDC MarketScape for Retail and CPG Customer Data Platform Software Providers

BOSTON–(BUSINESS WIRE)– Multi-award-winning pure-play customer data platform (CDP) BlueConic was recently named a Leader in the IDC MarketScape: Worldwide Retail and CPG Customer Data Platform...

Lunaphore deploys COMET™ at Propath UK

Propath UK is the first contract research organization in Europe to offer COMET™ services to biopharmaceutical researchers. LAUSANNE, Switzerland & HEREFORD, England–(BUSINESS WIRE)– Lunaphore, a...

Sky UK Renews Capacity With SES in Latest Multi-Year Deal

SES’s satellites continue to deliver SD, HD and UHD content for Sky UK’s subscribers LUXEMBOURG–(BUSINESS WIRE)– Audiences across the United Kingdom and the Republic of...

Ipsen: European Commission Approves Cabometyx® as a Second-Line Treatment for People Living With Radioactive Iodine-Refractory Differentiated Thyroid Cancer

Approval based on data from the COSMIC-311 Phase III trial, in which Cabometyx® (cabozantinib) demonstrated a 78% reduction in risk of disease progression or death...